Skip to content

INTROL CF Panel I Control v.02

by Mmqci 2 variants

Ref G106ac

INTROL CF Panel I Control v.02 (G106ac) is a cystic fibrosis IVD (EU IVDD general IVD; FDA Class II; FDA product code NZB, Quality Control Material, Genetics, Dna) made by Mmqci, registered in EUDAMED on 2 Nov 2026 (Basic UDI-DI B-00852720008015), cleared under FDA 510(k) K083171 on 16 Dec 2008 and listed in FDA GUDID since 24 Dec 2019 (UDI-DI 00852720008015), active as of 7 Nov 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 7 Nov 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K083171

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00852720008015 Basic UDI-DI 00852720008015UDI-DIDate2 Nov 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00852720008015 UDI-DI Date24 Dec 2019ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK083171 Date16 Dec 2008DecidedStatusActive

Official records

From the FDA record

Device description
This independent CF control is intended for in vitro diagnostic use to monitor the entire testing process of diagnostic assays used in the detection of the CFTR gene mutations and variants.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-00852720008015 registered 2 Nov 2026 Active
  • FDA 510(k) K083171 decided 16 Dec 2008 Active
  • FDA GUDID UDI-DI 00852720008015 listed 24 Dec 2019 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K083171
  2. Listed FDA GUDID 00852720008015
  3. Registered EUDAMED B-00852720008015

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
INTROL CF Panel I Control v.02 EUDAMED
INTROL CF Panel I Control GUDID
Generic name
Cystic fibrosis IVD, control
Model / Ref / Catalog
G106ac, v.02
Primary DI / UDI-DI
00852720008015
Basic UDI-DI
B-00852720008015
510(k) Number
FDA product code
NZB
EMDN code
W0106010101 Cystic fibrosis
GMDN term
Cystic fibrosis IVD, control
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
866.5910
EU registration type
Legacy device (under a directive)
EU market of registration
Belgium
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
G106ac
GUDID
v.02
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under MONOGENETIC DISORDERS.

Other devices from Mmqci

See all devices from Mmqci →

Properties

  • Reagent
  • IVD kit
  • Professional testing
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (19, all answered No)